Opis
Vitamin B12 ima vlogo pri delovanju imunskega sistema, prispeva k delovanju živčnega sistema, prispeva k sproščanju energije pri presnovi ter prispeva k normalnemu psihološkemu delovanju.
VITAMINI SKUPINE B PRISPEVAJO K:
- delovanju živčevja (B1, B2, B3, B7, B12),
- normalnem psihološkem delovanju (B3, B9, B12),
- zmanjšanju utrujenosti in izčrpanosti (B3, B9, B12, B2 in B5),
- ohranjanju zdravih sluznic in kože (B2, B3 in B7),
- delovanju srca (B1),
- umski zmogljivosti (B5).
Primerno tudi za vegane in vegetarijance. Proizvedeno na Švedskem.
Uporaba:
2 kapsuli Myrkl dnevno s kozarcem vode.
Sestava:
Fermentirani riževi otrobi (vsebuje Bacillus Subtilis, Bacillus Coagulans), kapsula (hidroksipropilmetil celuloza), mikrokristalna celuloza, L-cistein, sredstvi proti sprijemanju (magnezijeve soli maščobnih kislin, silicijev dioksid), dekstrin, vitamin B12 (cianokobalamin).
| Sestava: | 2 kapsuli | PDV* |
| Fermentirani riževi otrobi
– Od tega: – Bacillus Subtilis – Bacillis Coagulans |
553 mg
5000 CFU** 5000 CFU** |
/
/ / |
| L-cistein | 138,2 mg | / |
| Vitamin B12 | 0,9 µg | 36 % |
*Priporočen dnevni vnos
**Enote, ki tvorijo kolonijo
Opozorila:
Priporočenega dnevnega odmerka se ne sme prekoračiti. Prehransko dopolnilo ni nadomestilo za uravnoteženo in raznovrstno prehrano ter zdrav način življenja. Izdelek ni primeren za otroke, nosečnice in doječe matere. V primeru jemanja zdravil ali če imate zdravstvene težave, priporočamo, da se pred jemanjem posvetujete s svojim zdravnikom.
V primeru neuravnovešene prehrane preskrba s temi vitamini ni vedno optimalna. Poleg tega lahko telo le omejeno absorbira B-vitamine in jih skladišči le omejen čas. V primeru, da bi zaužili večjo količino npr. vitamina B1, telo en del neuporabljen izloči.
Pakiranje: 30 kapsul
Study Myrkl kapsule
Background: Regular alcohol consumption, e.g. by social drinking, is a potential source of consecutive health problems in many countries worldwide. A probiotic nutritional supplement (AB001) has been developed to reduce alcohol absorption from the intestine tract and to mitigate potential health care risks.
Methods: This randomized placebo-controlled double-blind crossover study was conducted with 24 healthy subjects (13 male, 11 female, age: 25.4 ± 7.7 years, BMI: 23.6 ± 2.5 kg/m²). The subjects were randomized to take 2 capsules/day of AB001 or placebo for 1 week prior to an alcohol exposure experiment. On the experimental day, they ingested a light breakfast and drank a moderate glass of spirit (0.3 g/kg body weight). Breath alcohol tests and blood draws for determination of blood alcohol levels were performed for up to 6 hours. After crossover, the experiment was repeated in the following week. Areas under the curves were calculated to determine alcohol absorption rates.
Results: A significant reduction of blood alcohol levels by 70.3% (P < 0.005 vs. placebo) was seen with AB001, (breath test: -30.7%; P < 0.005 vs. placebo). No difference was seen in a cognitive function test performed 60 minutes after alcohol ingestion (22.4 ± 7.7 seconds vs. 22.7 ± 5.6 seconds, n.s.). There were no adverse events or serious adverse events reported in this study.
Mnenja
Zaenkrat še ni mnenj.